Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
This study has been completed.
Information provided by:
NIH AIDS Clinical Trials Information Service
First received: November 2, 1999
Last updated: June 23, 2005
Last verified: May 1990
To evaluate the safety, tolerance, and pharmacokinetics of Retrovir (AZT) administration in HIV-infected patients in renal failure receiving maintenance hemodialysis.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by NIH AIDS Clinical Trials Information Service:
Contacts and Locations